Le Lézard
Classified in: Covid-19 virus
Subject: Survey

CWCI Study Tracks Trends in the Utilization of Inpatient Care in California Workers' Comp


A new California Workers' Compensation Institute (CWCI) study finds that after across-the-board declines in California inpatient hospitalizations during the COVID-19 heath crisis of 2020, the number of inpatient stays paid under Medicare, Medi-Cal, and private coverage all began to rebound in 2021, but the number of workers' compensation hospitalizations fell an additional 5.7%.

The latest results come from a CWCI study that measures and compares the use of inpatient services and procedures in different systems using data compiled by the state on more than 35.3 million hospital stays with 2012 through 2021 discharge dates. The 2021 decline in workers' compensation hospitalizations brought the total decline over the past decade to 48.1%, more than triple the 10-year decline of 15.0% noted for hospital stays paid under private coverage, while hospitalizations paid under Medicare were only down 5.2% and those paid by Medi-Cal increased by 11.7%. Workers' compensation is by far the smallest program analyzed, representing just 163,249 (<0.5 percent) of the California inpatient stays over the 10-year study period, and just 0.3 percent in 2021.

Most workers' compensation hospital stays are for the treatment of musculoskeletal and connective tissue disorders (between 58.1% and 66.0% of the stays since 2012), but COVID's impact is evident in the recent data, as the percentage of injured worker inpatient stays for the treatment of diseases and disorders of the respiratory system nearly tripled from 2.6% in 2019 to 7.4% in 2020 and remained at an elevated level (7.0%) in 2021. A review of the hospital stays for diseases and disorders of the respiratory system found that half were for respiratory infections and inflammation, though injured worker hospitalizations in this diagnostic category included a larger share of collapsed lungs or major chest traumas.

Surgical stays are far more prevalent in workers' compensation than in other systems, with the data showing they accounted for more than 2/3 of injured workers' inpatient hospitalizations in 2021, versus 24.7% for Medicare, 21.1% for Medi-Cal, and 31.5% for private coverage. Workers' compensation inpatient surgeries continue to be led by spinal fusions (17.6% of the 2021 surgeries) and major joint replacements (10.7 percent). Despite a sharp decline in workers' compensation spinal fusions (-59.1% since 2012), they are still far more prevalent among the injured worker inpatient population than among inpatients covered by Medi-Cal (0.6%), Medicare (1.3%); or private coverage (1.8%). As for workers' compensation joint replacement surgeries, the Institute found that 87.9% of all injured workers who underwent knee or hip replacements in 2021 were diagnosed with primary osteoarthritis, which tends to develop from mechanical wear and tear, structural degeneration, and joint inflammation, rather than from an acute, direct trauma to the joint associated with a specific injury. Furthermore, the decline in workers' compensation inpatient surgeries has been somewhat offset by an increase in the number of injured worker spinal fusions and total joint replacements performed on an outpatient basis. Using the state data and data from CWCI's IRIS database, the study found that the percentage of spinal fusions provided on an outpatient basis jumped from 0.8 percent in 2014 to 13.6 percent in 2021, while the percentage of total knee replacements performed on an outpatient basis increased from 0.2 percent in 2014 to 37.1 percent in 2021, with the biggest increase occurring in 2018, after Medicare removed the procedure from its "Inpatient Only" list.

More detailed findings from the CWCI study have been released in a Research Update Report, "Trends in the Utilization of Inpatient Care in California Workers' Compensation." CWCI members and subscribers can access the report and a summary Bulletin at www.cwci.org, while others can purchase a copy for $21 at www.cwci.org/store.html.


These press releases may also interest you

at 06:50
The "Nigeria Elevator and Escalator Market 2023-2029 Value, Size, Outlook, Industry, Analysis, Trends, Share, Revenue, Growth, Companies, COVID-19 Impact & Forecast: Market Forecast By Types, By Services, By End-User and Competitive Landscape" report...

at 06:30
The global microscopy market is poised for significant growth, expected to reach USD 10.6 billion by 2029 from USD 8.1 billion in 2024, growing at a CAGR of 5.4%. Key drivers include rising cases of chronic diseases necessitating effective...

at 06:00
Growing intervention by governments and climate agencies across the globe to adopt clean and low carbon fuel for automotive and industrial applications has been a key driving factor for the growth of renewable energy market, a trend that is expected...

at 05:45
The global Specialty Food Ingredients Market, valued at $107.4 billion in 2024, is on a trajectory of rapid expansion, with projections indicating it will soar to $155.2 billion by 2031, growing at a compound annual growth rate (CAGR) of 5.4% from...

at 05:30
The global Digital Healthcare Market, valued at $220.10 billion in 2024, is on a trajectory of rapid expansion, with projections indicating it will soar to $836.10 billion by 2031, growing at a compound annual growth rate (CAGR) of 21% from 2024 to...

3 jui 2024
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Gritstone bio, Inc. between March 9, 2023 and February 29, 2024, both dates inclusive (the "Class Period"), of the important August 6, 2024 lead plaintiff...



News published on and distributed by: